A detailed history of Acadian Asset Management LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 6,328 shares of IONS stock, worth $227,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,328
Holding current value
$227,238
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.06 - $51.86 $253,499 - $328,170
6,328 New
6,328 $253,000
Q1 2024

May 10, 2024

BUY
$42.03 - $53.55 $247,598 - $315,463
5,891 New
5,891 $255,000
Q1 2023

May 11, 2023

BUY
$33.58 - $41.2 $103,191 - $126,607
3,073 New
3,073 $109,000
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $745,050 - $992,177
20,390 New
20,390 $898,000
Q2 2021

Aug 11, 2021

SELL
$34.54 - $47.25 $82,136 - $112,360
-2,378 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$42.51 - $63.78 $1.36 Million - $2.04 Million
-32,026 Reduced 93.09%
2,378 $107,000
Q4 2020

Feb 11, 2021

BUY
$45.3 - $60.27 $418,889 - $557,316
9,247 Added 36.76%
34,404 $1.95 Million
Q3 2020

Nov 09, 2020

SELL
$47.45 - $62.95 $1.58 Million - $2.1 Million
-33,366 Reduced 57.01%
25,157 $1.19 Million
Q2 2020

Aug 12, 2020

BUY
$46.85 - $61.05 $2.69 Million - $3.51 Million
57,420 Added 5205.8%
58,523 $3.45 Million
Q1 2020

May 11, 2020

SELL
$41.6 - $63.4 $79,331 - $120,903
-1,907 Reduced 63.36%
1,103 $52,000
Q4 2019

Feb 06, 2020

BUY
$53.85 - $65.27 $162,088 - $196,462
3,010 New
3,010 $182,000
Q3 2019

Nov 07, 2019

SELL
$59.06 - $72.15 $56,874 - $69,480
-963 Closed
0 $0
Q2 2019

Aug 08, 2019

BUY
$62.09 - $86.14 $1,490 - $2,067
24 Added 2.56%
963 $62,000
Q1 2019

May 09, 2019

SELL
$52.92 - $81.17 $152,885 - $234,500
-2,889 Reduced 75.47%
939 $76,000
Q4 2018

Feb 07, 2019

BUY
$43.37 - $59.54 $159,167 - $218,511
3,670 Added 2322.78%
3,828 $207,000
Q2 2018

Jul 24, 2018

BUY
$40.53 - $50.7 $4,458 - $5,577
110 Added 229.17%
158 $7,000
Q1 2018

Apr 12, 2018

SELL
$44.08 - $55.05 $122,586 - $153,094
-2,781 Reduced 98.3%
48 $2,000
Q4 2017

Jan 18, 2018

SELL
$50.3 - $64.39 $27,715 - $35,478
-551 Reduced 16.3%
2,829 $143,000
Q3 2017

Oct 13, 2017

BUY
$45.56 - $59.57 $153,992 - $201,346
3,380
3,380 $171,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.1B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.